What is narcolepsy?
narcolepsy is a serious and debilitating neurological condition characterized by:
- Excessive daytime sleepiness
- Cataplexy (sudden reduction or loss of muscle tone while someone’s awake)
- Vivid hallucinations at the onset of sleep
- Sleep paralysis
- Disrupted nighttime sleep
How many people are living with narcolepsy?
Narcolepsy affects an estimated 185,000 individuals in the U.S.
- Narcolepsy has been shown to occur in people of any race, and shows up most commonly in people aged 15‑30
Cataplexy is seen in an estimated 70% of people living with narcolepsy, and is typically triggered by strong emotions like fear, anger, stress, or excitement.
What’s the impact of narcolepsy?
Narcolepsy interferes with your thinking, emotional and social functioning, increases the risk of work- and driving‑related accidents, and is linked to a 1.5x higher mortality rate. Up to 57% of those living with narcolepsy also report having depression.
Treatment options for narcolepsy are limited
- Most of the currently-approved therapies for the treatment of narcolepsy are DEA scheduled, controlled substances
- These treatment options:
- Do not address all of the symptoms of narcolepsy
- Differ in their effectiveness
- Have significant side effects
- Narcolepsy interferes with your thinking, emotional and social functioning, increases the risk of work- and driving-related accidents, and is linked to a 1.5x higher mortality rate
- Up to 57% of those living with narcolepsy also report having depression